Skip to main content
OpenTrials
Completed

NCT Number: NCT01411020

Target-controlled Infusion of Propofol for Induction of Pediatric Anesthesia

The purpose of this study is to determine a effect-site concentration of propofol in children 3 to 11 years effective to make a induction of general anesthesia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–11 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Hospital Clinico Universidad Catolica

Santiago, Santiago Metropolitan, Chile

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • obtained informed consent
  • children between 3 and 11 years
  • healthy
  • elective surgery under general anesthesia
  • no premedication

Exclusion criteria

  • body mass index for age > 95th percentile
  • chronic or acute intake of any sedative drug
  • any known adverse effect to the study drugs

Treatment and study plan

Endotracheal Intubation

Procedure

to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,

Primary outcomes

  1. dose of propofol

    Time frame: two days (duration of hospitalization)

    to obtain a dose appropriate of propofol in induction of anesthesia

Sponsors and collaborators

Lead sponsor

Pontificia Universidad Catolica de Chile

Other

Registry information

Official study title

Target-controlled Infusion (TCI) of Propofol for Induction in Children 3 to 11 Years

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Aug 5, 2011
Registry last updated
May 15, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.